当前位置: X-MOL 学术Light Sci. Appl. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Metastatic status of sentinel lymph nodes in breast cancer determined with photoacoustic microscopy via dual-targeting nanoparticles
Light: Science & Applications ( IF 19.4 ) Pub Date : 2020-09-16 , DOI: 10.1038/s41377-020-00399-0
Yanfeng Dai 1 , Xiang Yu 1 , Jianshuang Wei 1 , Fanxin Zeng 1 , Yiran Li 1 , Xiaoquan Yang 1 , Qingming Luo 1, 2 , Zhihong Zhang 1, 2
Affiliation  

Detection of sentinel lymph nodes (SLNs) is critical to guide the treatment of breast cancer. However, distinguishing metastatic SLNs from normal and inflamed lymph nodes (LNs) during surgical resection remains a challenge. Here, we report a CD44 and scavenger receptor class B1 dual-targeting hyaluronic acid nanoparticle (5K-HA-HPPS) loaded with the near-infra-red fluorescent dye DiR-BOA for SLN imaging in breast cancer. The small sized (~40 nm) self-assembled 5K-HA-HPPSs accumulated rapidly in the SLNs after intradermal injection. Compared with normal popliteal LNs (N-LN), there were ~3.2-fold and ~2.4-fold increases in fluorescence intensity in tumour metastatic SLNs (T-MLN) and inflamed LNs (Inf-LN), respectively, 6 h after nanoparticle inoculation. More importantly, photoacoustic microscopy (PAM) of 5K-HA-HPPS showed a significantly distinct distribution in T-MLN compared with N-LN and Inf-LN. Signals were mainly distributed at the centre of T-MLN but at the periphery of N-LN and Inf-LN. The ratio of PA intensity (R) at the centre of the LNs compared with that at the periphery was 5.93 ± 0.75 for T-MLNs of the 5K-HA-HPPS group, which was much higher than that for the Inf-LNs (R = 0.2 ± 0.07) and N-LNs (R = 0.45 ± 0.09). These results suggest that 5K-HA-HPPS injection combined with PAM provides a powerful tool for distinguishing metastatic SLNs from pLNs and inflamed LNs, thus guiding the removal of SLNs during breast cancer surgery.



中文翻译:

通过双靶向纳米粒子用光声显微镜确定乳腺癌前哨淋巴结的转移状态

前哨淋巴结(SLN)的检测对于指导乳腺癌的治疗至关重要。然而,在手术切除过程中区分转移性前哨淋巴结与正常和发炎的淋巴结 (LN) 仍然是一个挑战。在这里,我们报道了一种装载有近红外荧光染料 DiR-BOA 的 CD44 和 B1 类清道夫受体双靶向透明质酸纳米颗粒 (5K-HA-HPPS),用于乳腺癌 SLN 成像。皮内注射后,小尺寸(约 40 nm)自组装 5K-HA-HPPS 在 SLN 中快速积累。与正常腘窝淋巴结 (N-LN) 相比,纳米粒子照射后 6 小时,肿瘤转移性淋巴结 (T-MLN) 和发炎淋巴结 (Inf-LN) 的荧光强度分别增加约 3.2 倍和约 2.4 倍接种。更重要的是,5K-HA-HPPS 的光声显微镜 (PAM) 显示,与 N-LN 和 Inf-LN 相比,T-MLN 中的分布显着不同。信号主要分布在T-MLN的中心,但分布在N-LN和Inf-LN的外围。5K-HA-HPPS 组 T-MLN 的 LN 中心与周边的 PA 强度(R)之比为 5.93 ± 0.75,远高于 Inf-LN(R  = 0.2 ± 0.07) 和 N-LN ( R  = 0.45 ± 0.09)。这些结果表明,5K-HA-HPPS注射结合PAM提供了区分转移性SLN、pLN和发炎LN的有力工具,从而指导乳腺癌手术期间SLN的去除。

更新日期:2020-09-16
down
wechat
bug